Inventor · disambiguated record
Catherine Igartua
Also filed as: IGARTUA CATHERINE
5 granted patents·11 pending applications·41 citations·filing 2019–2024
78Inventor score
Top patents by PatentIndex Score
16 records- 0192US11043283B1Systems and methods for automating RNA expression calls in a cancer prediction pipelineTEMPUS LABS INC·Filed 2020·Granted Jun 22, 2021·12 cites·54 claims
- 0290US11527323B2Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2020·Granted Dec 13, 2022·15 cites·8 claims
- 0390US10975445B2Integrated machine-learning framework to estimate homologous recombination deficiencyTEMPUS LABS INC·Filed 2020·Granted Apr 13, 2021·12 cites·31 claims
- 0485US11164655B2Systems and methods for predicting homologous recombination deficiency status of a specimenTEMPUS LABS INC·Filed 2020·Granted Nov 2, 2021·2 cites·26 claims
- 0575US2025364135A1Systems and methods for multi-label cancer classificationTEMPUS AI INC·Filed 2024·Application pending·0 cites
- 0669US2023114581A1Systems and methods for predicting homologous recombination deficiency status of a specimenTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 0769US2022335306A1Techniques for resolving discordant her2 status in pathology images for diagnosing breast cancerTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 0868US2022351805A1Systems and methods for detecting cellular pathway dysregulation in cancer specimensTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 0967US2022028482A1Systems and methods for predicting homologous recombination deficiency status of a specimenTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1065US2021272649A1Systems and methods for automating rna expression calls in a cancer prediction pipelineTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1165US2023187070A1Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 1263US11367508B2Systems and methods for detecting cellular pathway dysregulation in cancer specimensTEMPUS LABS INC·Filed 2020·Granted Jun 21, 2022·0 cites·35 claims
- 1362US2021142904A1Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1458US2023253070A1Systems and Methods for Detecting Cellular Pathway Dysregulation in Cancer SpecimensTEMPUS LABS INC·Filed 2023·Application pending·0 cites
- 1547US2020098448A1Methods of normalizing and correcting rna expression dataTEMPUS LABS INC·Filed 2019·Application pending·0 cites
- 1644US2020210852A1Transcriptome deconvolution of metastatic tissue samplesTEMPUS LABS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Catherine Igartua files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →